UM

Browse/Search Results:  1-2 of 2 Help

Selected(0)Clear Items/Page:    Sort:
A redox-sensitive and RAGE-targeting nanocarrier for hepatocellular carcinoma therapy Journal article
Fang X.-B., Xu Y.-Q., Chan H.-F., Wang C.-M., Zheng Q., Xiao F., Chen M.-W.. A redox-sensitive and RAGE-targeting nanocarrier for hepatocellular carcinoma therapy[J]. Molecular Pharmaceutics, 2016, 13(11), 3613-3625.
Authors:  Fang X.-B.;  Xu Y.-Q.;  Chan H.-F.;  Wang C.-M.;  Zheng Q.; et al.
Favorite | TC[WOS]:6 TC[Scopus]:7 | Submit date:2018/11/07
Hcc  Oridonin  Pluronic F68  Rage  Redox-sensitivity  
A Redox-Sensitive and RAGE-Targeting Nanocarrier for Hepatocellular Carcinoma Therapy. Journal article
Fang, X., Xu, Y., Chan, H.F., Wang, C., Zheng, Q., Xiao, F., Chen, M.. A Redox-Sensitive and RAGE-Targeting Nanocarrier for Hepatocellular Carcinoma Therapy.[J]. Molecular Pharmaceutics, 2016, 3613-3615.
Authors:  Fang, X.;  Xu, Y.;  Chan, H.F.;  Wang, C.;  Zheng, Q.; et al.
Favorite |   IF:4.5/4.6 | Submit date:2022/01/25
Hcc  Rage  Oridonin  Pluronic F68  Redox-sensitivity